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Therapy Oncology Group (RTOG) protocol 1306. 
Determination of isocentre, beam arrangement and dose 
constraints were kept constant in each case. All plans were 
computed using Varian Eclipse version 11.0 treatment 
planning system. The plans were then evaluated based on the 
target coverage, homogeneity, conformity, number of 
monitor units (MU) to be delivered and dose-volume 
constraints for various organs at risk (OARs). 
 
Results: All plans exhibited comparable PTV homogeneity (HI 
≤ 7.5) and conformity (CI > 96%) with a steep dose fall-off 
outside the PTVs but at the expense of increased MUs by 
39.4% (p=0.007) and 44.7% (p=0.005) for FFF beams at 6 MV 
and 10 MV respectively. FFF beams offered better dose 
sparing of OARs than flattened beams. Spinal cord+5mm and 
volume of 'whole lung (WL) – Gross tumour volume (GTV)' 
(WL-GTV) that received 20Gy (V20) were reduced by 2% 
(p=0.017) and 2.8% (p=0.016) respectively in X10FFF plans 
when compared with X10FF plans. There was also a 16.4 % 
dose reduction to brachial plexus in X10FFF plans than X6FFF 
plans. 
 
Conclusion: The application of FFF IMRT for NSCLC yielded 
quantitatively comparable dosimetric distribution with better 
sparing of the OARs including ‘spinal cord+5mm’, V20 of ‘WL-
GTV’ and brachial plexus than using FF beams. 
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Purpose or Objective: There are few studies comparing 3-
dimensional conformal radiation therapy (3DCRT) and 
volumetric modulated arc therapy (VMAT) in treatment of 
esophageal cancer. These studies often compare 3DCRT 
unsophisticated, with few treatment beams, which is not 
common in clinical practice.  
Our aim was to compare a modern 3DCRT plan with VMAT 
using dose volume histograms (DVH) and evaluate the 
dosimetric profile.  
 
Material and Methods: We evaluate 7 patients with 
esophageal cancer (4 medium, 2 distal and 1 upper 
neoplasms). All were contoured using PET-CT and treated 
with radio-chemotherapy. Target volumes for primary lesions 
(50-50,4 Gy) and electively treated regions (45 Gy) were 
contoured. 
Every patient had 2 dose-plans, one with 3DCRT (8-10 beams) 
and other with VMAT (2 arcs) techniques. For each technique, 
we evaluate the coverage target, homogeneity index of PTV 
(HI), conformity index (CI), monitor units and DVH metrics of 
lungs, heart and spinal cord. 
 
Results: VMAT plans reduced total lung volume treated above 
20 Gy (V20) and mean lung dose (MLD), but volume treated 
above 5 Gy (V5) were higher than 3DCRT. VMAT improved 
total heart volume treated above 20 Gy and 40 Gy (V20, V40) 
and maximum dose to cord.  
Monitor units (MU) were higher with the 3DCRT. HI and CI are 
better with VMAT technique. Coverage target was very high 
with both schemes. Statistically meaningful differences were 
observed (Table 1). 
 
Conclusion: Our results suggest that VMAT for radical 
treatment of esophageal cancer is useful for decreasing dose 
in organs at risk. It can play a more important role in some 
locations, such as cervical cancer. Nevertheless, VMAT 
increases low-doses in lung and this may contribute increase 
pulmonary complications.  
A complex multibeam technique -3DCRT preserves constraint 
of organs at risk with high conformity and homogeneity of the 
target. 
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Purpose or Objective: The aim was to investigate whether 
the amplitude level achieved during DIBH impacted on the 
mean cardiac dose and V30 reduction in 30 women treated 
for a left sided breast cancer during radiotherapy. 
 
Material and Methods: Patients were dual scanned in free 
breathing and DIBH. Varian Real-time Position Management 
(RPM) was used to record and monitor breathing. Plans were 
virtually simulated with field borders following IMPORT high 
guidelines. Pinnacle treatment planning software was used 
for dosimetric calculation; all plans conformed to ICRU 62. 
Spearman’s Rank correlation and statistical analysis was 
performed using SPSS v22. All patient data was annonymised. 
To improve reliability and assess validity of the researcher, 
10 of the 30 patients were chosen at random, re-outlined and 
re-planned to confirm consistency and intra-rater reliability. 
The heart was also re-contoured for one patient 5 times to 
calculate the error in heart contouring. 
 
Results: All patients achieved decreased cardiac V30 and 
mean cardiac dose reduction using DIBH technique. Moderate 
positive correlation between DIBH amplitude and cardiac V30 
reduction was statistically significant (p=0.007, R=0.48). 
Ratio increase from free breathing to DIBH and cardiac V30 
reduction was also positively correlated and statistically 
significant (p=0.04, R=0.38). Twenty seven percent of 
patients achieved full cardiac V30 reduction and 73% of 
patients achieved over 90% reduction. Ratio of amplitude 
increase from free breathing to DIBH ranged from 4-27 times 
with ratios of at least 15 times free breathing all achieving 
100% cardiac V30 reduction. However 100% cardiac V30 
reduction was observed with amplitude of ratio increase as 
low as 6.25 times free breathing.  
Positive correlation between DIBH amplitude and mean 
cardiac dose reduction was statistically significant (p=0.003, 
R=0.523). Seventy seven percent of patients achieved over 
50% mean cardiac dose reduction with DIBH amplitudes of 
1.04-5.46cm. Correlation of ratio of amplitude increase from 
free breathing to DIBH and mean cardiac dose reduction was 
not statistically significant (p=0.316, R=0.189). 
 
Conclusion: A 100% reduction in cardiac V30 can be achieved 
with a DIBH amplitude increase 15 times free breathing, yet 
full reduction can also be achieved at much lower levels 
(6.25 times free breathing in the current study) suggesting 
patients unable to achieve a large amplitude increase may 
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still be able to achieve 100% reduction. DIBH amplitudes of 1-
5cm reduce cardiac mean dose by at least 50%. 
 
PO-1004  
Optimising breast dosimetry: improving homogeneity 
through the application of angled IMRT fields 
M. Squires
1Radiation Oncology Centres, Gosford, Gosford, Australia 
1, S. Cheers1 
 
Purpose or Objective: Studies have demonstrated significant 
side effects associated with dose inhomogeneity and low dose 
integral splay. Several techniques seek to maximise dose 
uniformity whilst minimising regions of low dose. The angled 
segment technique offers two additional options, each 
allowing for control over homogeneity (HI) and low dose 
conformity (CI).  
 
Material and Methods: Tangent fields of twenty previously 
optimised plans were copied. Two re-optimisation methods 
were applied. Firstly, a single medially angled off inversely 
planned (I-IMRT) beam was appended to the existing 
beamset. The plans were further optimised and normalised 
(PTV V47.5 = 99.00%). Secondly, an additional acutely 
laterally angled off I-IMRT beam was added, reoptimised, and 
normalised.  
 
Results: The addition of the single I-IMRT beam resulted in a 
statistically similar average absolute maximum dose (Dmax 
54.55Gy vs. 54.71Gy, p=0.33) but a markedly reduced V107% 
(14.71cc vs. 23.17cc, p<0.01). Low dose (V1) integral splay 
was maintained (6410.04cc vs. 6402.45cc, p=0.44), but was 
reduced marginally contralaterally (V1 splay over midline 
6.60cm vs. 6.80cm, p=0.04). Dose to the ipsilateral lung was 
slightly reduced (5.23Gy vs. 5.33Gy, p=0.04). The additional 
duel angled off I-IMRT fields reduced the average maximum 
dose (Dmax 53.79Gy vs. 54.71Gy, p=0.03) and the V107% size 
substantially (1.90cc vs. 23.17cc, p<0.01). Homogeneity was 
improved (HI= 0.11 vs. 0.13, p=0.03), whilst the ipsilateral 
mean lung dose was unaffected (5.33Gy vs. 5.33Gy, p=0.48). 
The volume of the low dose (V1) integral splay increased by 
an average of 1.5% (6501.14cc vs. 6402.45cc, p=0.04), and 
appeared further contralaterally (8.40cm vs. 6.80cm over 
midline, p=0.02).  
 
Conclusion: The application of additional acutely angled 
fields provides scope to reduce regions of high dose and 
improve breast homogeneity while controlling integral dose 
splay. 
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Purpose or Objective: Since 2000 we have been treating 
low- and intermediate-risk prostate cancer patients with 
permanent Iodine-125 implants. After 6 weeks postimplant 
dosimetry (PID) was performed using the Pro-Qura technique 
(Allen et al, 2008). In a previously performed study in our 
institute (cohort of 394 patients), we found that the 
dosimetric quantifier V100 was not correlated with 
biochemical relapse. Therefore, we examined the PID 
method to obtain more detailed information on the quality of 
the PID parameters. From the literature it appeared that in 
PID many uncertainties affect the quantifiers: delineation, 
source identification and imaging modalities (De Brabandere 
et al, 2012). In 2014 we started working with an automated 
seed reconstruction system (Elekta) to eliminate 
uncertainties in source identification. However, the other 
uncertainties still remained. Furthermore, the craniocaudally 
length of the Ultrasound (US) prostate contour was distally 
more extended compared to the contour on the postplan CT-
scan. This could be explained by the deformation of prostate 
by the US probe. The main purpose of this study was to 
determine the differences in PID based on US- or CT-
contours. 
 
Material and Methods: For 71 patients in supine position an 
axial CT-scan (1 mm slice thickness) was made of the 
prostate. One radiation therapist (RTT) performed the PID 
using the US prostate contour fused with the postplan CT-
scan. The apex area was defined as the volume derived from 
a quarter of the base-apex distance. We analyzed the V100 of 
the apex area and selected the patients with a coverage of 
less than 67%. Thereafter, we randomly selected 2 groups of 
patients: Group A: 5 patients with an optimal postplan 
implantation in the apex area conform Pro-Qura.Group B: 5 
patients with an inferior implantation result in the apex area, 
a coverage of less than 67%. For each patient, one radiation 
oncologist delineated the prostate on the CT-scan, trying to 
ignore the seeds. With that new delineated prostate the RTT 
performed a PID and these CT-based results were compared 
to the original results. To see the difference in length of the 
prostate on both modalities, we defined the last slice of the 
visible apex on both US and CT. 
 
Results: Between the US- and CT-scan volume an absolute 
difference was found of 12% (SD 2%). In both groups we 
found, in four out of five patients, that the apex on CT was 
positioned less caudally compared to the US-scan, figure. 
This was 4 and 10mm for group A and B respectively. 
 
 
 
Figure: Delineated prostate volumes. Red: US; Yellow: CT.  
For all patients, we found in both groups a significantly 
higher V100 using the prostate contours of the CT-scan. 
 
Conclusion: The volume of the prostate depends on the 
image modality. Consequently, the PID results differ as a 
function of image modality. This needs to be studied in a 
larger cohort of patients and could help to define on which 
modality the delineation and the PID needs to be performed. 
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Purpose or Objective: IMRT optimises not only the planned 
dose, but also the clinical preparation and treatment 
delivery. Until recently, our hospital used a standard 3DCRT 
for the breast, thoracic wall and lymph nodes ranging from 
level I to IV, including the parasternum. This usually leads to 
inconsistent OAR sparing, PTV coverage and conformity, 
abutting region from multiple fields and long treatment times 
due to many, high-MU fields. The objective of this study was 
to develop a hybrid 3DCRT-IMRT technique for locoregional 
breast irradiationl, which is also “breath-hold friendly” i.e. 
fewer MUs and fields. This technique should optimise 
planning and treatment times, maintain or reduce dose to 
OAR, improve PTV homogeneity, avoid the use of wedges and 
minimise the number of abutting beams. 
